Crescita Therapeutics Inc (CTX) — Cash Flow Reinvestment Rate
Crescita Therapeutics Inc (CTX) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting CA$724.00K (capex CA$724.00K ) from operating cash flow of CA$416.00K. Check CTX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Crescita Therapeutics Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Crescita Therapeutics Inc across 5 annual periods. Explore Crescita Therapeutics Inc (CTX) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Crescita Therapeutics Inc (2019–2025)
Year-by-year capital reinvestment analysis for Crescita Therapeutics Inc. For live market cap and broader valuation context, see CTX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CA$333.00K | CA$1.07 Million | CA$333.00K | ▼ -73.6% |
| 2024 | 1.18x | CA$3.20 Million | CA$2.73 Million | CA$1.19 Million | ▲ +817.6% |
| 2023 | 0.13x | CA$266.00K | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.02x | CA$118.00K | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.08x | CA$430.00K | CA$5.31 Million | CA$215.00K | — |